These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7308269)

  • 41. The pharmacokinetics and pharmacodynamics of furosemide in the anaesthetized dog.
    Hirai J; Miyazaki H; Taneike T
    J Vet Pharmacol Ther; 1992 Sep; 15(3):231-9. PubMed ID: 1433485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of furosemide on the renal prostaglandin system in liver cirrhosis with ascites].
    Mansurov KhKh; Dustov AD
    Klin Med (Mosk); 1989 Oct; 67(10):78-81. PubMed ID: 2615314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
    González-Martín G; Bravo I; Ibarra N; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Furosemide disposition in cirrhotic patients.
    Sawhney VK; Gregory PB; Swezey SE; Blaschke TF
    Gastroenterology; 1981 Dec; 81(6):1012-6. PubMed ID: 7286579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of furosemide on diuresis and salt diuresis, blood electrolytes concentrations in various aspects of renal function in liver cirrhotic patients with ascites].
    Bardi A; Merino I; Doerr E; Rendic Y; Generini G; Plaza de los Reyes M
    Rev Med Chil; 1968 Mar; 96(3):142-4. PubMed ID: 5732745
    [No Abstract]   [Full Text] [Related]  

  • 46. The influence of age on renal and extrarenal effects of frusemide.
    Andreasen F; Hansen U; Husted SE; Mogensen CE; Pedersen EB
    Br J Clin Pharmacol; 1984 Jul; 18(1):65-74. PubMed ID: 6743491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics of furosemide in patients with congestive heart failure.
    Greither A; Goldman S; Edelen JS; Benet LZ; Cohn K
    Pharmacology; 1979; 19(3):121-31. PubMed ID: 523503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased natriuretic efficiency of furosemide in rats with carbon tetrachloride-induced cirrhosis.
    Jonassen TE; Sørensen AM; Petersen JS; Andreasen F; Christensen S
    Hepatology; 2000 Jun; 31(6):1224-30. PubMed ID: 10827146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Furosemide kinetics in renal failure.
    Tilstone WJ; Fine A
    Clin Pharmacol Ther; 1978 Jun; 23(6):644-50. PubMed ID: 648078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attenuation of furosemide's diuretic effect by indomethacin: pharmacokinetic evaluation.
    Smith DE; Brater DC; Lin ET; Benet LZ
    J Pharmacokinet Biopharm; 1979 Jun; 7(3):265-74. PubMed ID: 480148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
    Dodion L; Ambroes Y; Lameire N
    Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure.
    Knauf H; Mutschler E
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):394-400. PubMed ID: 8583780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
    Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S
    BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the pharmacokinetics and pharmacodynamics of torasemide and furosemide in healthy volunteers.
    Lesne M
    Arzneimittelforschung; 1988 Jan; 38(1A):160-3. PubMed ID: 3370062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of insulin-induced changes in the renal response to furosemide in normal subjects.
    Sechi LA; Marigliano A; Tedde R
    Miner Electrolyte Metab; 1991; 17(6):383-9. PubMed ID: 1823389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Furosemide pharmacodynamics: effect of respiratory and acid-base disturbances.
    Babini R; du Souich P
    J Pharmacol Exp Ther; 1986 May; 237(2):623-8. PubMed ID: 3084762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Population-based meta-analysis of furosemide pharmacokinetics.
    Van Wart SA; Shoaf SE; Mallikaarjun S; Mager DE
    Biopharm Drug Dispos; 2014 Mar; 35(2):119-33. PubMed ID: 24151207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema.
    Perez J; Sitar DS; Ogilvie RI
    Br J Clin Pharmacol; 1980 May; 9(5):471-8. PubMed ID: 7397063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.